Back to BAYRYView full pipeline
Phase 3
Development Phase
0
Upcoming Catalysts
0
Historical Events
0
Regulatory Approvals
No Catalysts Found
No catalyst events have been recorded for this drug yet.
Competitive Landscape
0 competitors in Carcinoma, Hepatocellular
View Full LandscapeDrug Information
Patent & Exclusivity
No patent data available. Pre-approval drugs may not have Orange Book listings.
Drug Science
Mechanism of action & safety profile
Developer
Related Pipeline
D,L-lysine acetylsalicylate (Aspirin, BAY81-8781) 500 mg IVPhase 3
Acute Coronary Syndrome
Oxybutynin (Oxytrol, BAY839380)Phase 3
Overactive Bladder
Amikacin Inhalation Solution (BAY41-6551)Phase 3
Pneumonia, Bacterial
Finerenone (Kerendia, BAY94-8862)Phase 3
Chronic Kidney Disease
Regorafenib (Stivarga, BAY73- 4506)Phase 3
Colorectal Neoplasms
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts